Viscocid (500 mg+100 mg)/5 ml (Oral Suspension)

Title and Categories

• Viscocid Antacid Tablets
• Medicine
• Healthcare Product
• Gastrointestinal Relief
• Antacid

Description

• Treatment of symptoms resulting from the reflux of acid, bile, and pepsin into the esophagus
• Relief from acid regurgitation, heartburn, and indigestion
• Suitable for use after gastric surgery, during pregnancy, and with hiatus hernia
• Effective for laryngopharyngeal reflux symptoms such as hoarseness and voice disorders
• Can be used during concomitant treatment with or following the withdrawal of acid suppressing therapy

Dimensions

• Tablet size: various dimensions
• Suspension bottle size: various capacity

Dosage and Administration

• Tablet dosage for adults and children over 12 years
• Tablet dosage for children 6-12 years
• Suspension dosage for adults and children 12 years and above
• Suspension dosage for children 2-12 years
• Not recommended for children under 2 years of age
• No dose modifications for the elderly
• No dose modifications for individuals with hepatic impairment
• Caution with highly restricted salt diet in case of renal insufficiency

Mode of Action

• Combination of Sodium Alginate and Potassium Bicarbonate
• Formation of a gel reacting with stomach acid
• Generation of carbon dioxide bubbles to create a protective raft in the stomach
• Physical action, not dependent on absorption into systemic circulation
• Raft lasts up to 4 hours and is excreted in the feces

Interaction

• Consider a 2-hour interval between intake and administration of certain medicinal products
• Includes tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine

Contraindications

• Contraindicated in patients with known hypersensitivity to Sodium Alginate and Potassium Bicarbonate

Side Effects

• Possible side effects: nausea, constipation, diarrhea, headache
• Consult a physician in case of significant dosage or sensation of swelling

Pregnancy and Lactation

• Can be used during pregnancy if clinically needed
• No known effect on breast-fed infants
• Safe for use during breastfeeding

Precautions and Warnings

• Prescribed with caution in patients with renal impairment and congestive cardiac failure
• Care needed in treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal calculi
• Possibility of reduced efficacy in patients with very low levels of gastric acid
• Review clinical situation if symptoms do not improve after seven days

Overdose Effects

• Overdosage rare, consult a registered physician in case of an overdose

Therapeutic Class

• Antacids

Storage Conditions

• Store below 30°C, away from light and moisture
• Keep out of the reach of children

Related Brands

• Algicid (500 mg+100 mg)/5 ml (Oral Suspension) - incepta-pharmaceuticals-ltd
• Algisum 500 mg+100 mg (Chewable Tablet) - opsonin-pharma-ltd
• Algisum (500 mg+100 mg)/5 ml (Oral Suspension) - opsonin-pharma-ltd
• Asynta (500 mg+100 mg)/5 ml (Oral Suspension) - square-pharmaceuticals-plc
• Xerocid 500 mg+100 mg (Chewable Tablet) - novelta-bestway-pharma-ltd